Merck pill now awaiting FDA authorization after adviser endorsement
Advisers from the U.S. Food and Drug Administration have narrowly approved an endorsement of the Merck COVID-19 pill, voting 13 to 10 in favor of the authorization.
If authorized, it would be the first easy-to-take antiviral pill for COVID-19. Pfizer is also working on a COVID-19 pill, which it hopes will be authorized early next year. The FDA typically takes the advice of its advisers but will make its own final decision.
During Tuesday’s meeting, advisers spoke positively on Merck's pill, even though it was not found to be quite as effective in the final analysis as it was in an early, preliminary analysis.
However, the advisers expressed doubt about whether it would be safe for pregnant people to use Merck's pill because of the potential risk of harm to the fetus as well as its use in children due to lack of data and similar concerns as in pregnancy.
-ABC News' Sony Salzman